Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

Clinical trial NCT04539301 · UNKNOWN

Trial details

NCT number: NCT04539301
Sponsor: Nantes University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Anticoagulation Venous Thromboembolism Atrial Fibrillation

Start date: 2021-04-01
Primary completion: 2024-05-01
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.